abstract |
The present application relates to processes for the preparation of oseltamivir and the H 3 PO 4 salt of oseltamivir, TamifluĀ®. The application further relates to novel intermediate compounds and to pharmaceutical compositions containing said compounds. The application further relates to a method of using the novel intermediates to treat or prevent influenza. |